<--> SHORE-C: Sussex Health Outcomes Research and Education in Cancer

New Data Manager Post

we are hiring

Applications are invited for a Data Manager to join SHORE-C within BSMS at the University of Sussex. Applicants should ideally have an MSc or equivalent in Information Systems. Experience working in any oncology, research or healthcare setting would be an advantage.More details and application here ...

SHORE-C celebrates two decades on Sussex campus


SHORE-C have been on the University of Sussex campus for 20 years! Read the University of Sussex news item. and Val Jenkins' interview with 'My Sussex Life'.

Remote consultations for cancer patients to be evaluated

The COVID-19 pandemic has rapidly ushered in changes to the cancer consultation experience for patients and clinicians. To accommodate social distancing, the traditional way of meeting in person in a clinic room is now the exception, with most discussions conducted by telephone or video-link, commonly referred to as ‘remote consultation’. For both parties this means new ways of communicating and interacting.

SHORE-C is carrying out a service evaluation of remote consultations, led by Dr Sue Catt with collaboration from clinical colleagues (Dr Richard Simcock and Dr Leroy Okonta), and called REFLECTIONS (REmote Follow-up consultations: Lessons and Experiences during Covid-19 Time In ONcology Services).

The REFLECTIONS evaluation aims to highlight the benefits and challenges of remote consultations from the perspectives of oncologists and their patients. Over the next six months, one-off interviews, lasting about 45 minutes, will be conducted with a sample of patients treated by the Sussex Cancer Centre and consultants who work there. Ethical approval is in place, recruitment opened this week and the first few patients approached have expressed interest in participating.

Dr Catt said: "The findings of our evaluation will be used to identify areas that could be improved and positive elements that may be capitalised on to ensure consultations in the future get maximum benefit from alternative ways of working." (article from InPulse, BSMS internal weekly newsletter, issue 219, 09 October 2010)

Dame Lesley has been made an Ambassador for the Martlets Hospice in Hove

Martlets Hospice

Dame Lesley has been made an Ambassador for the Martlets Hospice in Hove. Commenting on the appointment, she says: "I have always been an enormous admirer and supporter of the hospice movement having been encouraged as a young researcher by Dame Cicely Saunders herself who started the hospice movement in the UK. I was then really privileged to work with Professor Colin Murray-Parkes at the Royal London Hospital who did pioneering research at St Christopher's Hospice on loss and bereavement. Few people realise that hospices get very little of their funding from the NHS and are dependent on the generosity of the general public. The COVID pandemic has led to huge financial difficulties for the Martlets and other hospices with the cancellation of fun runs, marathons, closure of charity shops and other events such as the Halloween Ball. Along with my other illustrious Ambassadors I hope that we can work with the fundraising team to ensure that the vital amazing work of our local hospice can continue."

Certificate in Counselling Studies for Lucy

Lucy Matthews, our Clinical Trials Coordinator, has passed her Level 3 Certificate in Counselling Studies. Lucy will now begin a part-time Postgraduate Diploma in Psychodynamic Psychotherapeutic Counselling at the University of Brighton.

Falmer Magazine features the work of Professor Dame Lesley Fallowfield and SHORE-C.

Falmer magazine cancer care image

"Ensuring that people aren't fatigued, depressed or feeling sick shouldn't be a luxurious add-on." Read the article here

Rachel appointed as media representative for BPOS

Rachel Starkings, Research Fellow here at SHORE-C, has been appointed as a media representative to the British Psychosocial Oncology Society (BPOS) executive committee. This is a three-year appointment and she'll be sharing the role with Dr David Wright, a Senior Research Fellow at the Macmillan Survivorship Research Group. The committee is always looking for new ways to engage people so Rachel hopes this will be an exciting challenge. Find out more about the committee here. (article from inPulse - BSMS internal e-newsletter - Issue 207 - 26 June 2020)

British Psychosocial Oncology Society (BPOS) Conference, Edinburgh 2020

SHORE-C researchers at BPOS Professor Dame Lesley Fallowfield gave a talk on 'Helping nurses discuss risk and uncertainty about chemotherapy with early breeast cancer (EBC) patients: results from novel educational workshops'

Several SHORE-C researchers attended the BPOS conference in Edinburgh where they all presented posters about our current research.

Farewell and good luck!

Dr Val Shilling at her desk

Dr Val Shilling is leaving SHORE-C for the second time - so see her soon!! A huge thanks to Val. Her new post is Programme Manager for the NHS England National Cancer Programme (Quality of Life). We wish Val all the best in her future career!

Farewell to Dr Sue Catt and good luck!

Dr Susan Catt

A huge thanks to Dr Susan Catt who left SHORE-C this month after working here for 19 years. Before joining SHORE-C in 2002, Sue had already covered a lot of ground. She trained as a nurse at St George's, London, did a BSc in Psychology at Warwick, worked on her MSc and PhD at Reading and had post-doc positions in Edinburgh and London. She worked on many studies at SHORE-C, and we will miss her.

Senior Research Positions

Applications are invited for two Senior Research Fellows to join SHORE-C within BSMS at the University of Sussex. Applicants must have a PhD in Health Psychology or related discipline and post-doctoral experience in areas such as the design and/or interpretation of patient reported outcome measures, clinical or intervention trials, interviewing skills and/or teaching communication. More details and application here ...

Professor Valerie Jenkins Inaugural Lecture - November 2019

Val Jenkins inaugural lecture

More than 170 people attended, including colleagues from SHORE-C and local sixth form students. Prof Jenkins presented her research in communicating about clinical trials, studies exploring the phenomenon of 'brain fog' and reflected on her career in psycho-oncology. The lecture was introduced by Prof Debra Humphris (above left), Vice-Chancellor at the University of Brighton, and concluded by Prof Malcolm Reed (right), Dean at BSMS.

Professor Valerie Jenkins Inaugural Lecture, Wednesday November 13

Lesley and Val at San Diego

A night out in San Diego!

Lesley and Val at San Diego

Dame Lesley and Dr Val Shilling are presenting papers on SHORE-C's recently developed patient and caregiver roles and responsibilities scales at the 26th ISOQOL Annual Conference in San Diego, California.

Kathryn Monson, SHORE-C's Senior Trials Manager, presented a poster at the fifth International Clinical Trials Methodology Conference, held on 6–9 October at the Hilton Brighton Metropole.

Katherine Monson

The International Clinical Trials Methodology Conference is organised by the Medical Research Council Network of Hubs for Trials Methodology Research. It provides a platform for clinical trials researchers and statisticians to present their work on methodological aspects such as novel trial design, improving patient recruitment, data management and statistical analysis. Kathryn Monson, Senior Trials Manager from Sussex Health Outcomes Research and Education in Cancer (SHORE-C), attended the conference and presented a poster on patient-reported outcome data collected in the 'POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy' (POSNOC) trial. More info here.

Post Menopausal Research Discussion on Radio BBC Sussex

Dr Helena Harder

Dr Helena Harder, Research Fellow at Sussex Health Outcomes, Research and Education in Cancer (SHORE-C) featured on BBC Sussex's 'Drive at 5' show this week. Helena discussed a study she led, which found that less than a quarter of postmenopausal UK women are sexually active and a mere 3% are happy with their sex life. Listen to the interview by clicking on the image above (the interview starts at 20 minutes in).

Filming for TRUSTING at SHORE-C

picture of filming for TRUSTING

We are producing a new educational series, which aims to help healthcare professionals when discussing genetic testing with patients and their families who are a high genetic risk of breast, ovarian and prostate cancer. More news to follow ...

SHORE-C article finds that many postmenopausal UK women have disappointing sex lives

Less than a quarter of postmenopausal UK women are sexually active and a mere 3% are happy with their sex life, according to a our new study. We analysed free text comments made on a sexual activity questionnaire by more than 4,000 women taking part in an ovarian cancer screening trial (UKCTOCS). Four major classification themes were identified: partner availability, physical and sexual health, mental wellbeing and interpersonal relationships. Despite 65% of women having partners, findings showed that only around a third of these women were sexually active. Just 3% referred to positive sexual experiences, yet only 6% had sought help for their sexual problems.

Press coverage for SHORE-C article on sexual functioning in older women

Following the online publication of "Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis ", articles about the study are published today in the news media including in Reuters, Yahoo!, and The Daily Mail.

Film of the publication!

Many postmenopausal UK women have disappointing sex lives. According to our new study on sexual_functioning in 4,418 postmenopausal women in the UK, less than a quarter are sexually active and a mere 3% are happy with their sex life.


Congratulations to Lucy Matthews, our Clinical Trials Coordinator, who obtained her level II certificate in counselling studies this month.

Breast Cancer Research Foundation fund two new films for SHORE-C

Lesley and film crew

We have been busy filming two new scenarios to add to our Breast Cancer Research Foundation funded TARGET (Talking about Risk in the Context of Genomic Tests) educational program for clinicians working in breast cancer. The scenarios deal with giving risk of recurrence results using Prosigna - a genomic test that was recently approved by the National Institute for Health and Care Excellence. The production was funded by Nanostring; one scenario starred Dr Marina Parton from the Royal Marsden Hospital (pictured with Lesley and the actors), and the other featured Dr Judy King from the Royal Free Hospital, London.

TARGET paper - Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians published and online

target word map of treatments

The paper, with results from the seven TARGET workshops held over the past year, has been accepted by Breast Cancer Research and Treatment. Thanks to all the clinicians who attended. You can read the paper here.

Academy of Medical Science DEPARTURE LOUNGE

Dame Lesley was interviewed on Radio Five Live by Adrian Chiles last week about death and dying and the Academy of Medical Science project, The Departure Lounge. You can find the innovative public engagement space in Lewisham Shopping Centre. Two of our researchers, Rachel Starkings and Dr Susan Catt, were facilitators, spending two days each there last week and over the weekend. The Academy of Medical Sciences want to demystify death and it was designed to encourage conversations about death and tackle some of the taboos around dying.

ESO Umberto Veronesi Memorial Award

Dame Lesley receiving her Umberto Vronesi Foundation Prize

Dame Lesley was awarded the Umberto Veronesi Foundation prize at this year's St Gallen International Breast Cancer Conference, which took place in Vienna on 20-23 March. Prof Veronesi, who died in 2016 aged 90, contributed enormously to the research showing that all women with breast cancer did not necessarily need to have a mastectomy. Dame Lesley was given the award in recognition of her leading role in advancing science and care of breast cancer patients.

Dame Lesley giving her lecture at Gallen

Commenting on the award, she said: "I am absolutely thrilled and immensely proud that the Awards Committee have nominated me, a psycho-oncologist rather than a surgeon, for this prestigious award. I knew Prof Veronesi well and he was always very kind and encouraging to me in the early stages of my career. I am sure that the title of my talk 'How heretical thoughts and challenging orthodoxy improves breast cancer care' which epitomised his own private and professional life, would make him smile.

BPOS 2019, Chester, UK

Two of our researchers, Lucy Matthews and Rachel Starkings are at BPOS in Chester. Here Lucy presents some results from the EXTREQOL study.

New mentoring lead for BSMS

The BSMS Inclusivity Team is delighed that Dr Val Shilling has taken on the role of mentoring working group lead. Dr Shilling replaces Dr Sara Balouch, who started a new position at BPP University in January. Dr Shilling brings a wealth of experience to the role having been both a mentee and mentor in the scheme.

Welcome to our new member of staff, Elizabeth Renvoize!

Beth joins us as Department Assistant. Good luck to her and all for 2019!

New illustrated eBook: Communicating with people newly diagnosed with cancer

front cover of 'Communicating with people newly diagnosed with cancer' ebook

Available to download from the Apple iTunes store, for iPad, iPhone or Mac. Inspired by his experiences with cancer for over 30 years, Bruce Gilligan considers the most effecive ways to communicate with newly diagnosed cancer patients.

Elizabeth Hurley at SHORE-C - 2018

Elizabeth Hurley takes part in research into breast cancer treatment

The research is being carried out by Dame Lesley Fallowfield, Professor of Psycho-oncology at Brighton and Sussex Medical School, in partnership with Dr Melanie Flint, reader in cancer biology at the University of Brighton.

the SHORE-C Team

Elizabeth Hurley has taken part in research exploring the benefits of yoga, exercise and mindfulness on those being treated for breast cancer. See our bWell app for exercises after breast cancer, which you can download from the App Store.

The actress, 53, hailed the work as “ground-breaking” during a visit to the laboratory at Brighton and Sussex Medical School, where the team is exploring whether stress reduction techniques can increase the effectiveness of chemotherapy for those with breast cancer. Hurley, the global ambassador for Estee Lauder’s Pink Ribbon breast cancer awareness campaign, had her saliva tested to measure levels of the hormone cortisol, which indicates stress.

'Problem Solving in Person-Centred and Integrated Cancer Care' is the BMA Oncology Book of the Year!

BMA First Prize for Problem Solving in Person-Centred and Integrated Cancer Care Certificate

Against significant competition from some excellent titles, ours was chosen as the best in category. The ACP series in oncology from EBN Health has won the award for the last three years which is a great achievement for all authors and editors. You can see the titles at www.ebnhealth.com.

Please email Duncan Enright, Managing Director, ebn health, for a copy of the book or more information

Talking about Risk and UncertaintieS of Testing IN Genetics (TRUSTING)

Professor Dame Lesley Fallowfield has been awarded a grant from the prestigious Breast Cancer Research Foundation in the US to develop a communication skills programme to help HCPs discuss germline mutations in breast cancer, and the management options available to patients.

Professor Val Jenkins and the Dame busy making a new patient information film with Prof Denis Talbot, Consultant medical oncologist at Oxford.
ECP Video - a great film production team!

Congratulations to Professor Val Jenkins!

Da iawn!! Our very own Professor Valerie Jenkins has been made a professor - the Dame says 'Richly deserved and well overdue!!!'

Umberto Veronesi Award for Prof Dame Lesley Fallowfield

Dame Lesley will be awarded the Umberto Veronesi Foundation prize at next year's St Gallen International Breast Cancer Conference, which will take place in Austria in March 2019. Prof Veronesi, who died in 2016 aged 90, contributed enormously to the research showing that all women with breast cancer did not necessarily need to have a mastectomy. Prof Dame Fallowfield is being given the award in recognition of her leading role in advancing science and care of breast cancer patients. Commenting on the award, she said: "I am absolutely thrilled and immensely proud that the Awards Committee have nominated me, a psycho-oncologist rather than a surgeon, for this prestigious award. I knew Prof Veronesi well and he was always very kind and encouraging to me in the early stages of my career. I am sure that the title of my talk 'how heretical thoughts and challenging orthodoxy improves breast cancer care' would make him smile."

BPOS 2018

Four of us went to BPOS (British Psychosocial Oncology Society) annual conference this year. Our director, Professor Dame Lesley Fallowfield, was awarded a BPOS Lifetime Membership Award. Lucy Matthews gave a talk on ENDOPREDICT and Rachel Starking displayed our PEPSIN poster. You can read more about the conference here.

Dr Helena Harder, Research Fellow at SHORE-C, in the news, telling us about her current research. Spotlight on Dr Helena Harder

Retirement for Tracy

SHORE-C is sorry to see the well-earned retirement of Tracy Woodcock.

San Antonio

Dame Lesley and Professor Val Jenkins at the San Antonio Breast Cancer Symposium in December

British Science Festival Talk by Professor Dame Lesley Fallowfield

For most women, being diagnosed with breast cancer causes significant emotional stress. The pressure of making important decisions about treatments, which often come with distressing side effects, can increase anxiety. Dame Lesley Fallowfield discussed her research into the psychological impact of breast cancer and showed how doctors can minimise stress by improving communication around risk and uncertainty of test results and recommended treatments.


Dr Val Shilling presented a poster at the 20th annual European Congress of International Society for Pharmacoeconomics and Outcomes Research in Glasgow on 8th November 2017. 

The poster titled Evaluation and validation of the PROACT measures for cancer patients and informal caregivers describes the development of two new scales measuring broad life impacts of cancer and cancer treatment for patients and informal caregivers.


Best poster prize for Lucy Matthews for her AVALPROFS poster. What a great end to a great conference!

PROACT lucky construct poster at BPOS

PROACT 'lucky' construct poster at BPOS

SHORE-C and CU Fitter

Sue with CUFitter poster

Sue Catt explaining the CUFitter poster at the BPOS conference.

SHORE-C researchers are collaborating with Cancer United, a cancer patient support group based in Littlehampton.

Patient Reported Outcomes

Dame Lesley is quoted in a recent Medicine Matters Oncology online article titled 'The time is right for Patient Reported Outcomes'

SHORE-C and CU Fitter

SHORE-C researchers are collaborating with Cancer United, a cancer patient support group based in Littlehampton. Their CU Fitter initiative was recently covered by ITV Meridian news on 29th January 2017. Click here to view the ITV Meridian News item

Cancer Survivorship Conference

Professor Dame Lesley Fallowfield and Dr Val Shilling presented posters at the ASCO Cancer Survivorship Symposium: Advancing Care & Research in San Diego California on 28th January 2017. To view the posters, click on the titles below:

Do drugs that offer PFS or modest OS benefits improve quality of life in patients with advanced cancer?  

Uncertainty about the future for patients with advanced cancer and their informal caregivers: A qualitative view.

Measuring the impact of extended cancer survival on broader aspects of life and wellbeing: The PROACT Study.



Dr Val Shilling presented a PROACT poster at the International Society for Quality of Life Research (ISOQOL) 23rd Annual Conference in Copenhagen, Denmark. Read more on the PROACT page.

Rachel Starkings also presented this poster at the Inaugural Postdoctoral Research Day on the 2nd of November 2016. The poster explored the first two phases of the PROACT study and was awarded first prize on the day. More information on the study can be found on the PROACT page.

Photo: Dr Val Shilling

'For services to psycho-oncology' lecture on YouTube

It was a full house for Professor Dame Lesley Fallowfield's lecture 'For services to psycho-oncology' Psycho what?' which took place on 22 September 2016.

Dame Lesley gave a fascinating account of her career to date alongside a parallel history of the field of psycho oncology.  

A video of the lecture is now available on YouTube for those who missed the event via this link For services to psycho-oncology

Photo: BSMS Dean Malcolm Reed and University of Sussex VC Prof Adam Tickell with Dame Lesley

New Grant Award - 2016

Professor Dame Lesley Fallowfield has been awarded a prestigious Breast Cancer Research Foundation (BCRF) grant of $250,000 annually.

The BCRF is the highest rated breast cancer organisation in the US and eminent researchers are invited to apply for funding. Dame Lesley proposed two distinct projects.

One is to produce a communication-skills DVD/workshop for clinicians discussing genomic test results with breast cancer patients; the other working with Dr Melanie Flint at Brighton University and UK breast oncologists, will examine the psycho-neuroimmunological and biological factors underpinning personalised supportive interventions for women with breast cancer.

Lecture on 22nd September 2016

Pilot Workshops 19th & 20th September 2016

Talking with Patients about Metastatic Bone Disease (MBD) workshops were facilitated by Professor Dame Lesley Fallowfield on Monday September 19th (Prostate Cancer) and Tuesday September 20th (Breast Cancer) at the RNLI College in Poole.

The pilot workshops were aimed at clinicians and nurses treating and caring for breast and/or prostate cancer patients with Metastatic Bone Disease (MBD). The workshops used a set of 5 newly created educational videos illustrating different MBD consultations. The scenarios do not show the “right” or “wrong” way to discuss MBD but are used as “triggers” to engage participants in discussion.



Professor Dame Lesley Jean Fallowfield

"Professor Fallowfield, Professor of Psycho-Oncology at Brighton and Sussex Medical School, is an exceptional scientist who has transformed the way health professionals communicate with cancer patients and improved their quality of care. She has pioneered quality-of-life assessment in cancer trials and the tools she has developed for this are now used worldwide. Her work has also significantly improved the recruitment of patients into clinical trials. She was Chair of the British Breast Group, which brings together UK experts in breast cancer, and sits on numerous panels, advisory boards and guidelines development groups that aim to ensure quality cancer care for patients."

^ Top

UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Trial Results

UKCTOCS CC and RC Leads 2015

The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) mortality results and psychological outcomes were published on 17/12/2015 at a public meeting in London and also in the Lancet. To read about the study and for links to the public meeting and publications click Herered arrow

^ Top



Professor Lesley Fallowfield appeared in the Sky News Sunrise programme on 1st October 2015 as part of the Estee Lauder Companies' UK Breast Cancer Awareness Campaign which asks the difficult question, ‘What happens afterwards?’.

To inspire and offer guidance to those who have been affected by breast cancer, The Estée Lauder Companies UK BCA Campaign has published a collection of advice and short anecdotes on returning to ‘normality’ from real people who have lived through breast cancer. Lesley wrote the foreword to this book titled 'Afterwards, Reflections on Life beyond Breast Cancer' commented: ‘It’s difficult to appreciate fully the psychological and physical impact the diagnosis and treatment of breast cancer has if you’ve not been through it. For some it is an emotional catastrophe, for others an opportunity to reappraise many aspects of their lives. This campaign illustrates the different ways -­‐ some poignant, many uplifting, that women and their loved ones can live well through and beyond a breast cancer diagnosis’. Read 'Afterwards' onlinered arrow

^ Top

Lesley Fallowfield posted this photo of herself with Paula Beetlestone in the Green Room waiting to appear on London Live.


Professor Lesley Fallowfield is quoted in a BMJ news item titled ‘NHS England drops 16 medicines from Cancer Drugs Fund’. Read morered arrow


Professor Lesley Fallowfield participated on the expert panel at the "Health Lies and Videotape" event in Brighton on the evening of Monday 7th September 2015. The event was organised by the Academy of Medical Sciences and sponsored by the Wellcome Trust. More information about this series of events is available on the Academy of Medical Sciences website


The new LORIS clinical trial website is now live. Click here to view the website. www.birmingham.ac.uk/loris


SHORE-C are collaborating on a new study to investigate the use of a prognostic tool called EndoPredict® to inform adjuvant chemotherapy decisions in Early Breast cancer. Read morered arrow


Professor Lesley Fallowfield is quoted in two articles relating to changes in the Cancer Drugs Fund recently announced. Please click on the article titles below to read them in full.

"25 cancer drugs to be denied on NHS" in The Telegraph on 12th January 2015

"Cancer patients in Britain may die sooner as drugs cutbacks are imposed" in the Irish Times on 13th January 2015

^ Top



A new article is IN PRESS titled "The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ” in Clinical Oncology. Read morered arrow


A blurring of professional boundaries can affect young cancer doctors’ objectivity when treating patients, according our online survey completed by 338 young (under the age of 40 years) oncologists throughout Europe in August. Results showed that 60% felt that if doctors were too empathetic then they could not make objective decisions, while 59% also thought it difficult to be truthful about prognosis if they particularly liked a patient.

Despite this, around a quarter of respondents had treated family members, and a third had treated friends. Most allowed patients to use their first name, and 60% allowed patients to hug or kiss them in greeting or saying goodbye. Such behaviours are not always wrong but could be liable to misinterpretation in a highly charged clinical setting.

Director of SHORE-C and Professor of Psycho-Oncology at BSMS, Lesley Fallowfield, said: “Oncology can be a very emotionally challenging field in which to work. Cancer patients need their doctors to be warm, compassionate and caring but the relationship should not be confused with a social one. Burnout in young oncologists is high, at more than 30%, and often leads to them leaving the profession. Any blurring of professional boundaries can also play a part in the stress faced by oncologists in dealing with patients with a life-threatening illness.”

The rise of mobile technology and social media may add to this blurring of boundaries, with more than half (55%) the doctors admitting they had given their personal mobile numbers to patients and 14% even accepting invitations from patients to be ‘friends’ on Facebook.

Prof Malcolm Reed, the incoming Dean of BSMS, said: “Although these results need replicating, they show a worrying trend. The General Medical Council (GMC) has produced guidance in which these newer risks to the maintenance of professional boundaries are made clear; they need to be promoted to students and young doctors.”

Prof Fallowfield agrees and her team will be designing such a programme. She commented: “It is so important that patients have strong and trusting relationships with their doctors during what will most likely be a very emotional and difficult period. Young oncologists clearly understand that and, as our survey shows, often invest a lot of personal time and emotional energy into doing what they believe to be helpful. But to ensure that cancer patients receive the best and most objective treatment, oncologists must look after their own emotional well-being also and recognise that there needs to be a professional line over which one just shouldn’t cross.”

The commentary is published in the 1st December issue of The Lancet Oncology.

This article was further reported in The Times Health News section on Monday 24th November 2014 and by BBC World Service radio the same morning in the 'World Update' programme (47 minutes 36 seconds into the episode).

^ Top


Niamh Foley from University College Cork, Ireland presented her PATI-project development and demonstrate an iPad application for breast cancer patients. Niamh, a graduate of Trinity College Dublin and has been engaged in postgraduate surgical training since 2008.  During a full-time MD, Niamh had the opportunity to work with Mr Mark Corrigan, Consultant Breast Surgeon at Cork University Hospital and PATI was developed with financial support from the Translation Research Access Programme in University College Cork School of Medicine.

Patient Accessed Tailored Information (PATI) for Breast Cancer seeks to create a bank of easily understandable online modules explaining to breast cancer patients each step of their treatment using text, graphics and animation. Modules were designed following a patient information needs assessment and in conjunction with the National Adult Literacy Agency, and have been integrated into an online system to which the patient has personal access. At present the content is available through an application on 4 purpose-bought IPads. Patients from the breast care centre in CUH are being actively recruited to partake in a randomised control trial whereby half of the enrolled patients will be given the IPad one week prior to their scheduled operation and will return the IPad at their first post-operative visit. Several tools are being employed to evaluate this resource including:

  • Mini-Mental Adjustment to Cancer
  • Hospital Anxiety and Depression Scale
  • Information Satisfaction Questionnaire
  • Information Technology Usability Questionnaire

It is anticipated that this system will empower patients, targeting health literacy to reduce anxiety, increasing their knowledge and improving their capacity to consent to medical/surgical intervention.

^ Top


New study launched to design, develop and field-test a prototype application for smartphone and tablet use for self-management of postoperative exercises in women with breast cancer

Read morered arrow


LUCY MATTHEWS, Clinical Trials Co-ordinator here at SHORE-C, has won the prestigious ABS (Association of Breast Surgery) Prize for Best Oral Presentation at the Brighton and South East Breast Day. The event was held at the AMEX Stadium on 3rd October. Lucy's talk was on What’s in a name: how to accurately describe low grade Ductal Carcinoma in site (DCIS) to patients in relation to the Low Risk DCIS Trial (LORIS) Lucy is the QoL Trial Co-ordinator on the LORIS trial, just opening. The Prize was awarded by ABS Hon Sec Mr Simon Cawthorn.


The POSNOC Trial Patient Information DVD is available on youtube
Watch the DVD on YouTubered arrow


The POSNOC Trial was launched on Wednesday 7th May 2014
Read morered arrow


Professor Lesley Fallowfield's gave a plenary lecture entitled "Psychosocial/Survivorship Issues: are we doing better?" at the 36th Annual SABCS Dec. 10-14,2013.

^ Top